Wu Lihteh, Fernandez-Loaiza Priscilla, Sauma Johanna, Hernandez-Bogantes Erick, Masis Marissé
Lihteh Wu, Erick Hernandez-Bogantes, Marissé Masis, Vitreoretinal Section, Instituto de Cirugía Ocular, San José 1225, Costa Rica.
World J Diabetes. 2013 Dec 15;4(6):290-4. doi: 10.4239/wjd.v4.i6.290.
The global incidence and prevalence of diabetes mellitus (DM) have reached epidemic proportions. Estimates indicate that more than 360 million people will be affected by DM by 2030. All of these individuals will be at risk of developing diabetic retinopathy (DR). It is extremely important to categorize, classify and stage the severity of DR in order to establish adequate therapy. With proper management more than 90% of cases of visual loss can be prevented. The purpose of the current paper is to review the classification of DR with a special emphasis on the International Clinical Disease Severity Scale for DR. This new classification is simple to use, easy to remember and based on scientific evidence. It does not require specialized examinations such as optical coherence tomography or fluorescein angiography. It is based on clinical examination and applying the Early Treatment of Diabetic Retinopathy Study 4:2:1 rule.
糖尿病（DM）的全球发病率和患病率已达到流行程度。据估计，到2030年将有超过3.6亿人受到糖尿病的影响。所有这些人都有患糖尿病视网膜病变（DR）的风险。对DR的严重程度进行分类、分级和分期对于确定适当的治疗方法极为重要。通过适当的管理，90%以上的视力丧失病例可以得到预防。本文的目的是回顾DR的分类，特别强调糖尿病视网膜病变国际临床疾病严重程度量表。这种新的分类易于使用、易于记忆且基于科学证据。它不需要诸如光学相干断层扫描或荧光素血管造影等专门检查。它基于临床检查并应用糖尿病视网膜病变早期治疗研究4:2:1规则。
